Elanco Animal Health Reels Amidst Legal Turmoil: Is It an Investment Opportunity in Disguise?
Elanco Animal Health’s stock plummeted 7.04%, closing at $10.04, amid financial and legal challenges. Shareholder law firms allege Elanco misrepresented its Zenrelia drug’s safety and approval timelines. Broader market indices also fell, reflecting economic uncertainties and geopolitical tensions. Despite current issues, Elanco’s
